In a speech at the annual meeting of the American Society of Human Genetics on November 6, Francis Collins, the director of the National Institutes of Health and the man who headed the Human Genome Project, implored his colleagues in genetics to work to develop new treatments for rare diseases.
FORBES: Rare Disease Drugs: A $1 Trillion Market?